Top Markets
Coin of the day
Taro Pharmaceutical Industries Ltd. Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd.

TARO
Rangering i aksjer #7354
Taro Pharmaceutical Industries Ltd. operates as a scientifically-driven... Taro Pharmaceutical Industries Ltd. operates as a scientifically-driven pharmaceutical enterprise, specializing in the development, manufacturing, and commercialization of both prescription and over-the-counter medications. Its market reach spans the United States, Canada, Israel, and various other international territories. The company also produces active pharmaceutical ingredients (APIs), primarily for integration into its own finished dosage form products. Its extensive product catalog addresses a broad spectrum of medical conditions and therapeutic areas, encompassing treatments for allergies, pain (analgesic), bacterial and fungal infections (antibacterial, antibiotic, antifungal), seizures (anticonvulsant), nausea (antiemetic), inflammation (anti-inflammatory), cancer (anti-cancer, topical anti-neoplastic), blood clot prevention (antiplatelet agent), fever reduction (antipyretic), cardiovascular issues, central nervous system disorders, hormonal regulation (corticosteroid, endocrine), cosmetic applications, coughs and colds, dermatological complaints, fluid management (diuretic), gastrointestinal problems, constipation (laxative), severe pain (narcotics), neuropathic pain, neuropsychiatric conditions, and sleep/anxiety management (sedative/hypnotic). These pharmaceutical goods are available in numerous formats, including capsules, creams, drops, emulsions, gels (and gel kits), granules, injectables, lotions, oils, ointments, pastes, powders (and powders for solution), rectal suppositories, shampoos, solutions (and solutions for infusion), sprays, suspensions, syrups, tablets, toothpastes and mouthwashes, topical foams, and topical solutions. Taro distributes and sells its products directly to a wide array of clients, such as pharmaceutical wholesalers, retail drug store chains, food chains, hospitals, mass merchandisers, grocery chains, other direct purchasers, and various healthcare institutions and private pharmacies. The company was established in 1950, with its main offices situated in Haifa, Israel. Taro Pharmaceutical Industries Ltd. is a wholly-owned subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.
Aksjekurs
$42.98
Sist synkronisert: 2024-06-21
Markedsverdi
$1.62B
Endring (1 dag)
0.01%
Endring (1 år)
0.00%
Land
IL
Handel Taro Pharmaceutical Industries Ltd. (TARO)

Kategori

Antall utestående aksjer for Taro Pharmaceutical Industries Ltd. (TARO)
Antall utestående aksjer per March 2024: 37.58M
Ifølge Taro Pharmaceutical Industries Ltd. sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 37.58M. Ved slutten av March 2023 hadde selskapet 37.58M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Taro Pharmaceutical Industries Ltd. (TARO) fra 1999 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
2026 (TTM) 37.58M 0.00%
2024 37.58M 0.00%
2023 37.58M -0.15%
2022 37.64M -1.49%
2021 38.21M -0.65%
2020 38.46M -1.36%
2019 38.99M -2.90%
2018 40.16M -2.77%
2017 41.30M -3.58%
2016 42.83M 0.00%
2015 42.83M -3.26%
2014 44.28M -0.90%
2013 44.68M 0.00%
2012 44.68M 10.94%
2010 40.27M 2.65%
2009 39.23M 0.08%
2008 39.20M 12.89%
2007 34.73M 18.33%
2006 29.35M 0.33%
2005 29.25M 0.36%
2004 29.14M 1.03%
2003 28.85M 0.35%
2002 28.75M 22.75%
2001 23.42M 9.33%
2000 21.42M 6.30%
1999 20.15M 0.00%
Utestående aksjer for lignende selskaper eller konkurrenter